Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading health solutions company is seeking an Oncology RPh Advisor to support Medicare Part D members. This remote role involves evaluating prior authorization requests, collaborating with teams, and maintaining oncology knowledge. The ideal candidate will have a pharmacist license, BCOP certification, and clinical experience in oncology.
At CVS Health, we're building a world of health around every consumer and surrounding ourselves with dedicated colleagues who are passionate about transforming health care.
As the nation's leading health solutions company, we reach millions of Americans through our local presence, digital channels, and more than 300,000 purpose-driven colleagues—caring for people where, when, and how they choose in a way that is uniquely more connected, more convenient, and more compassionate. We do it all with heart, each and every day.
As an Oncology RPh Advisor in Government Services, you will support Medicare Part D members and providers with pharmacy benefit requests. Responsibilities include setting up cases accurately, reviewing clinical information, performing outreach to providers, and ensuring decisions comply with guidelines and timelines. You will also assist front-line colleagues with oncology processes, provide on-the-job training, and help develop clinical training sessions. Maintaining current oncology knowledge through education and certifications is essential. Collaboration with various teams and leadership is required.
This is a remote role open within the U.S., requiring availability from 9am-5:30pm EST, with flexibility for training or meetings.
BS in Pharmacy or PharmD. Required: Licensed Pharmacist and BCOP certification.
Remote work from an approved location.
Full-time, 40 hours/week. Pay range: $45.43 - $101.54/hour, depending on experience and other factors. Benefits include medical, 401(k), stock purchase, wellness programs, and more. Application deadline: 05/27/2025.